drugset / Trial / NCT01531699

Antimicrobial Efficacy of ALT005 Ophthalmic Prep Solution in Healthy Volunteers

NCT01531699

Phase 3 Completed 54 enrolled Altacor Ltd.
RandomizedParallel-groupOpen-labelPrevention

Summary

This is an open-label, randomized, single-dose, placebo-controlled efficacy study to assess the antimicrobial efficacy of ALT005 ophthalmic prep solution following dermal administration in healthy volunteers. Efficacy will be assessed by comparing the reduction in microbial load for up to 6 hours to that of saline control.

Timeline

Start
2012-02
Primary completion
2012-10
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject ALT005 Unknown Topical
Subject Povidone-Iodine Other / unclassified

Indications